[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644576":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":37,"collaborators":7,"id":39,"slug":7,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":40,"sex":46,"minAge":47,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"European Institute of Oncology","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Giuseppe Petralia, PhD","CONTACT","+39 0257489037","giuseppe.petralia@ieo.it",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"European Institute of Oncology, Milan","RECRUITING","Milan","Mi","20141","Italy","IT",{"type":24,"coordinates":25},"Point",[26,27],12.59836,42.78235,{"lat":27,"lon":26},[30,34],{"name":31,"role":11,"phone":32,"phoneExt":7,"email":33},"Lorenzo Conti, Researcher","+39 0294371083","Lorenzo.Conti@ieo.it",{"name":35,"role":36,"phone":7,"phoneExt":7,"email":7},"Giusppe Petralia, PhD","PRINCIPAL_INVESTIGATOR",{"type":38,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100644576",false,"NCT07671846","Patient Anxiety During Magnetic Resonance Imaging","Italian Translation and Cross-cultural Validation of a Questionnaire Evaluating Patient Anxiety During Magnetic Resonance Imaging: the Magnetic Resonance Imaging-Anxiety Questionnaire (MRI-AQ)","MRI-AQ","Inclusion Criteria:\n\n* Cancer patients who will perform a WB-MRI in their clinical path\n* Age ≥ 18 years\n* Patients able to speak and read the local language(s) fluently.\n* Patients with no concomitant neurological or psychiatric disorders.\n* Acceptance and signature of informed consent\n\nExclusion Criteria:\n\n* Absolute contraindication to WB-MRI\n* Previous cancer-related medical treatments or other treatments that could have altered patients' cognition","ALL","18 Years",{"count":49,"type":50},175,"ESTIMATED","OBSERVATIONAL","This study is a cross-sectional validation project that aims to translate the MRI-Anxiety Questionnaire (MRI-AQ) into Italian and adapt it culturally for cancer patients undergoing whole-body MRI. The protocol will recruit 175 adult patients at the European Institute of Oncology, use a forward-backward translation process, and evaluate the Italian version with the MRI-AQ itself plus the MRI Fear Survey Schedule (MRI-FSS). The main statistical goal is to show that the Italian version is not inferior to the original in terms of internal consistency. The ultimate purpose is to provide a specific, validated tool for measuring MRI-related anxiety in Italian oncology patients.",[54],"Cancer",[56,57],"Magnetic Resonance Imaging","Patient anxiety","2026-06-25",{"date":60,"type":61},"2026-06-26","ACTUAL",{"date":63,"type":61},"2026-05-06",{"date":65,"type":50},"2027-02-28",{"name":5,"class":6},1]